RISK ADAPTED MANAGEMENT WITH ADJUVANT CHEMOTHERAPY IN PATIENTS WITH HIGH RISK CLINICAL STAGE I NONSEMINOMATOUS GERM CELL TUMOR
- 1 June 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 163 (6) , 1785-1787
- https://doi.org/10.1016/s0022-5347(05)67543-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- LONG-TERM RESULTS FOLLOWING ADJUVANT CHEMOTHERAPY IN PATIENTS WITH CLINICAL STAGE I TESTICULAR NONSEMINOMATOUS MALIGNANT GERM CELL TUMORS WITH HIGH RISK FACTORSJournal of Urology, 1999
- IS RETROPERITONEAL LYMPH NODE DISSECTION NECESSARY FOR ADULT PARATESTICULAR RHABDOMYOSARCOMA?Journal of Urology, 1998
- COMPLIANCE OF CLINICAL STAGE I NONSEMINOMATOUS GERM CELL TUMOR PATIENTS WITH SURVEILLANCEJournal of Urology, 1998
- Organ Preserving Surgery of Malignant Germ Cell TumorsJournal of Urology, 1995
- Retroperitoneal Lymphadenectomy for Clinical Stage a Testis Cancer (1965 to 1989): Modifications of Technique and Impact on EjaculationJournal of Urology, 1993
- Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party.Journal of Clinical Oncology, 1992
- Staging Relationships and Outcome in Early Stage Testicular Cancer: A Report From the Testicular Cancer Intergroup StudyJournal of Urology, 1991
- Surgical Treatment of Stage-I Non-Seminomatous Germ Cell Testis TumorEuropean Urology, 1990
- HISTOPATHOLOGY IN THE PREDICTION OF RELAPSE OF PATIENTS WITH STAGE I TESTICULAR TERATOMA TREATED BY ORCHIDECTOMY ALONEThe Lancet, 1987
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987